Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-07-13
DOI
10.3389/fonc.2022.932337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sarcoma classification by DNA methylation profiling
- (2021) Christian Koelsche et al. Nature Communications
- Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
- (2021) Santhosh A. Upadhyaya et al. CLINICAL CANCER RESEARCH
- An analysis of the diagnosis, clinical characteristics, treatment, and survival outcomes of 36 extracranial malignant rhabdoid tumor patients
- (2021) Yuhua Shan et al. Translational Pediatrics
- Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children’s Oncology Group Trial ACNS0333
- (2020) Alyssa T. Reddy et al. JOURNAL OF CLINICAL ONCOLOGY
- SuperFreq: Integrated mutation detection and clonal tracking in cancer
- (2020) Christoffer Flensburg et al. PLoS Computational Biology
- Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1
- (2019) Christian Thomas et al. ACTA NEUROPATHOLOGICA
- Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)
- (2019) Fady M. Mikhail et al. GENETICS IN MEDICINE
- Unbiased metabolic profiling predicts sensitivity of high MYC-expressing atypical teratoid/rhabdoid tumors to glutamine inhibition with 6-diazo-5-oxo-L-norleucine
- (2019) Sabrina Z Wang et al. CLINICAL CANCER RESEARCH
- MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors
- (2019) Michaël H Meel et al. NEURO-ONCOLOGY
- Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
- (2019) Hye-Jung E. Chun et al. Cell Reports
- Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors
- (2019) Michael C Frühwald et al. NEURO-ONCOLOGY
- Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
- (2019) Ben Ho et al. NEURO-ONCOLOGY
- Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous
- (2018) Emilia M. Pinto et al. ACTA NEUROPATHOLOGICA
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1 deficient Group 2 Atypical Teratoid Rhabdoid Tumors to suppress tumor growth in vivo
- (2018) Irina Alimova et al. INTERNATIONAL JOURNAL OF CANCER
- Accelerating Discovery of Functional Mutant Alleles in Cancer
- (2017) Matthew T. Chang et al. Cancer Discovery
- Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
- (2016) Jonathon Torchia et al. CANCER CELL
- Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
- (2016) Pascal D. Johann et al. CANCER CELL
- Germline Mutations in Predisposition Genes in Pediatric Cancer
- (2015) Jinghui Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Churchill: an ultra-fast, deterministic, highly scalable and balanced parallelization strategy for the discovery of human genetic variation in clinical and population-scale genomics
- (2015) Benjamin J Kelly et al. GENOME BIOLOGY
- SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis
- (2014) Martin Hasselblatt et al. ACTA NEUROPATHOLOGICA
- The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Extracranial rhabdoid tumours: what we have learned so far and future directions
- (2013) Bernadette Brennan et al. LANCET ONCOLOGY
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
- (2012) D. C. Koboldt et al. GENOME RESEARCH
- Sequencing of Local Therapy Affects the Pattern of Treatment Failure and Survival in Children With Atypical Teratoid Rhabdoid Tumors of the Central Nervous System
- (2011) Atmaram S. Pai Panandiker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome
- (2010) Reinhard Schneppenheim et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors
- (2010) Katherine W. Eaton et al. PEDIATRIC BLOOD & CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started